Suchergebnisse

The COVID pandemic has swept through the world with significant consequences for our work and family lives. We have seen a huge upsurge in remote working, collaborating and leading and ways of working, giving rise to myriad challenges such as "Zoom fatigue," poor "digital demarcation," shifting workplace power balances, and declining mental health and safety. Its impact has rightly increased scholarly and practitioner attention towards better ways to support and understand employees, leaders, and organizations; and to help them to develop more effective responses to disruption of various forms. For volume 18 of the series Research on Emotion in Organizations we have fittingly chosen the theme, Emotions during Times of Disruption and contend that emotions and other affect related concepts represent keys to understanding the phenomena of disruption in organizations more fully. Literature to date addressing this issue is surprisingly scant and so chapters in this volume provide impactful and important contributions to an underexplored area. Emotions during Times of Disruption progresses through 4 thematic sections which include, Emotions in disruptive contexts, Emotions and performance-related outcomes during disruption, the role of supervisors and leader emotions during disruption and lessons learnt which help point the way forward with further insights and recommendations.

"Provides students and general readers with a basic understanding of the central concepts, issues, and thinkers of the early modern era of philosophy. s there a world that exists apart from ourselves? If an external world exists, what is its nature? Can an external world based on evidence from our sense perception be known? How do such questions arise? Is it even possible for them to be answered? This is Modern Philosophy: An Introduction surveys how philosophers from the late sixteenth century to the early nineteenth century investigated central metaphysical and epistemological issues. Focusing on six key philosophers, this accessible volume provides readers with a solid and balanced appreciation of how philosophy was done in the Modern period. Each chapter explores the views of a particular thinker—René Descartes, Thomas Hobbes, George Berkeley, David Hume, Immanuel Kant, and Lady Mary Shepherd—with special attention paid to their engagement with 'The Problem of the External World.' Throughout the book, readers are invited to consider related philosophical problems and doctrines, such as transcendental idealism, mind-body dualism, and skepticism"--

Eine robuste Bewertung des Klimarisikos und der ⁠Vulnerabilität⁠ ist für Unternehmen erforderlich, die die Taxonomiekonformität gemäß der EU-Taxonomieverordnung in Bezug auf wesentliche Beiträge zur Klimaanpassung für bestimmte Wirtschaftstätigkeiten erreichen wollen. Die entsprechenden rechtlichen Anforderungen sind in Anhang 1, Anlage A der delegierten Verordnung 2021/2139 definiert. Um die Umsetzung dieser Anforderungen zu erleichtern, hat das Umweltbundesamt die Empfehlung "Durchführung einer robusten ⁠Klimarisiko⁠- und ⁠Vulnerabilitätsanalyse⁠ nach EU Taxonomie" entwickelt. Diese Empfehlungen beschreiben wie ein Leitfaden, wie Unternehmen praktisch vorgehen können, um die gesetzlichen Anforderungen der Taxonomie zu erfüllen.

Cover -- Contents -- Chapter One: Birth Of Sead -- Chapter Two: Wild Weasel II, III and IV -- Chapter Three: Ultimate Weasels -- Chapter Four: 'Big George' -- Chapter Five: Storming Ahead -- Chapter Six: Southern Watch -- Appendices -- Colour Plates Commentary -- Index -- Imprint.

This scientific opinion paper outlines existing problems related to data gaps, non-harmonized assessments, insufficient post-market control, and data transparency of pharmaceuticals, and identifies possible solutions through the introduction of a monograph system for active pharmaceutical substances. From ⁠UBA⁠'s point of view, monographs are the crucial bridge between risk assessment, risk communication and risk management and this across different regulatory areas. The current revision of the general pharmaceutical legislation of the EU offers the opportunity to establish a monograph system for active substances for both veterinary medicinal products and medicinal products for human use.